Coverage
-
January 23, 2023
A Massachusetts federal judge on Monday consolidated a pair of proposed class actions alleging that Takeda Pharmaceutical broke antitrust law by cutting a pay-for-delay deal to keep a generic version of its anti-constipation drug Amitiza off the market for over six years.
1 other articles on this case.
View all »